ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FGEN FibroGen Inc

1.02
0.00 (0.00%)
After Hours
Last Updated: 19:21:08
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.02 19:21:08
Open Price Low Price High Price Close Price Prev Close
1.04 0.9754 1.06 1.04 1.02
more quote information »

Recent News

Date Time Source Heading
4/24/202416:02GLOBEFibroGen Announces Clinical Data from Dose Escalation Phase..
4/02/202417:46GLOBEFibroGen Announces Topline Results from Phase 1 Monotherapy..
3/26/202407:00GLOBEFibroGen to Present at 23rd Annual Needham Virtual..
3/11/202407:00GLOBEFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
3/08/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/26/202416:08EDGAR2Form 8-K - Current report
2/26/202416:06GLOBEFibroGen Reports Fourth Quarter and Full Year 2023 Financial..
2/26/202416:05GLOBEFibroGen Regains All Rights to Roxadustat from AstraZeneca..
2/23/202420:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202407:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2023..
2/14/202415:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/05/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202407:00GLOBEFibroGen To Host Part I of Virtual KOL Investor Event Series..
1/25/202407:00GLOBEFibroGen Announces Completion of the Pamrevlumab Arm in..
12/26/202319:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202317:02GLOBEFibroGen Presents Data from Phase 3 MATTERHORN Trial of..
11/06/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:05EDGAR2Form 8-K - Current report
11/06/202316:01GLOBEFibroGen Reports Third Quarter 2023 Financial Results
11/03/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/27/202316:30EDGAR2Form 8-K - Current report
10/23/202307:00GLOBEFibroGen to Report Third Quarter 2023 Financial Results
9/25/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202320:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202320:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202308:55EDGAR2Form 8-K - Current report
9/01/202319:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202317:31EDGAR2Form 144 - Report of proposed sale of securities
8/29/202317:14EDGAR2Form 8-K - Current report
8/29/202316:15GLOBEFibroGen Announces Topline Results from LELANTOS-2, a Phase..
8/14/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202317:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202319:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/07/202316:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/07/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:06EDGAR2Form 8-K - Current report
8/07/202316:01GLOBEFibroGen Reports Second Quarter 2023 Financial Results
8/04/202316:42EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock